👏 小分子|新冠病毒3CL非共价抑制剂ML300衍生物的结构优化

---
[TOC]

---


## 参考文献
1. Han S H, Goins C M, Arya T, et al. Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (SARS-CoV-2 3CLpro)[J]. Journal of Medicinal Chemistry, 2021, 65(4): 2880-2904. 